4.5 Article

(p40)2-Fc reduces immune-inflammatory response through the activation of T cells in collagen induced arthritis mice

期刊

IMMUNOLOGY LETTERS
卷 176, 期 -, 页码 36-43

出版社

ELSEVIER
DOI: 10.1016/j.imlet.2016.05.013

关键词

(p40)2-Fc; Rheumatoid arthritis; Osteoclastogenesis

资金

  1. R&D Program of MKE/KEIT[Development of Fc fusion protein for autoimmune disease using IL-23 antagonist] [10028480]
  2. Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0016]
  3. Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C3062]

向作者/读者索取更多资源

IL-12p40 homodimer, a natural antagonist of IL-12 and IL-23, performs an important role in the expression of proinflammatory cytokines that is essential for Th1 and Th17 immune responses. Here, we reveal the therapeutic and immunosuppressive effect of the IL-12p40 subunit ((p40)(2)-Fc) in an experimental autoimmune arthritis model. We hypothesized that (p40)(2)-Fc may reduce the inflammatory response and the activation of T cells. In this study, we intraperitoneally injected (p40)(2)-Fc into collagen induced arthritis (CIA) mice to identify whether (p40)(2)-Fc attenuates CIA severity. (p40)(2)-Fc reduced the development of CIA, joint inflammation and cartilage destruction. (p40)(2)-Fc also significantly decreased the concentration of serum immunoglobulin as well as the number of T cells and C II specific T cells. In addition, osteoclastogenesis in (p40)(2)-Fc treated mice was down-regulated compared to the mice treated with (p40)(2)-Fc control. We observed that (p40)(2)-Fc treatment alleviates arthritis in mice with CIA, reducing inflammation and osteoclast differentiation. These findings suggest that (p40)(2)-Fc can be a potential therapeutic approach for autoimmune arthritis. (C) 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据